PegaWORLD 2015: Clinical Trials Evolution: How Pfizer, Inc. is Using Pega to Improve their Clinical Operations (Presentation)
Pfizer, Inc. selected Pega to provide real-time understanding of the quality of clinical trial data, which enables proactive risk management, improved patient safety, and easier compliance. The new Pharmacovigilance (PV) Exchange module has modernized processes around risk-based activity monitoring (RBAM) and established a reusable platform. Additionally a business portal is being built as the authoritative source for Clinical Production Schedules during the course of a study.
- Veronica Trimble, Sr. Manager, Pfizer R&D Business Technology, Pfizer, Inc.
- Brian McVeigh, Pharmaceutical R&D Partner, Accenture